Hugh S. Taylor

ORCID: 0000-0003-1720-8310 · 312 papers in corpus
other 2020
Fertility and sterility ·doi:10.1016/j.fertnstert.2020.03.012
other 2020
Reproductive biology ·doi:10.1016/j.repbio.2020.08.005
lab-animal 2020
Journal of cellular and molecular medicine ·doi:10.1111/jcmm.14933

Adult stem cells have a major role in endometrial physiology, including remodelling and repair. However, they also have a critical role in the development and progression of endometriosis. Bone marrow-derived stem cells engraft eutopic endo…

review 2020
Therapeutic advances in reproductive health ·doi:10.1177/2633494120964517

While the most common symptom associated with endometriosis is pelvic pain, the systemic manifestations of the disease and the accompanying adverse psychological, emotional, social, familial, sexual, educational and workplace effects are in…

other 2020
Fertility and sterility ·doi:10.1016/j.fertnstert.2020.11.005
lab-animal 2020
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-020-00294-4

Endometriosis is an estrogen-dependent gynecological disorder that affects 10% of reproductive-aged women and causes pelvic pain and infertility. Bone marrow-derived stem cells (BMDCs) are known to engraft endometriosis in association with …

2020
·doi:10.1016/j.fertnstert.2020.08.240
review 2020
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-020-00164-z

Iron is an essential element for cell survival, and iron deficiency is a known risk factor for many reproductive disorders. Paradoxically, such disorders are also seen more commonly under conditions of iron excess. Here, we focus on the pro…

observational 2020
Fertility and sterility ·doi:10.1016/j.fertnstert.2020.01.036

OBJECTIVE: To determine the relationship between steroid receptor expression and pain symptoms in endometriosis. DESIGN: Cross-sectional SETTING: University Hospital PATIENT(S): Women with endometriosis (N = 92). INTERVENTION(S): Tissue s…

rct 2020
Obstetrics and gynecology ·doi:10.1097/AOG.0000000000003917

OBJECTIVE: To evaluate the effects of elagolix on clinically meaningful improvements in health-related quality of life (HRQOL) measured by the EHP-30 (Endometriosis Health Profile-30). METHODS: Data from two phase III trials of elagolix fo…

other 2020
Annals of translational medicine ·doi:10.21037/atm-2020-98
review 2020
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2020.06.004

Women's health concerns are generally underrepresented in basic and translational research, but reproductive health in particular has been hampered by a lack of understanding of basic uterine and menstrual physiology. Menstrual health is an…

2020
·doi:10.1016/j.fertnstert.2020.08.570
observational 2020
ClinicoEconomics and outcomes research : CEOR ·doi:10.2147/ceor.s264905

PURPOSE: Elagolix is an oral gonadotropin-releasing hormone antagonist approved in the United States for the management of moderate to severe pain associated with endometriosis. We performed a real-world evaluation of the demographic and cl…

rct 2020
Fertility and sterility ·doi:10.1016/j.fertnstert.2020.07.013

OBJECTIVE: To evaluate the utility, responsiveness, and thresholds for clinically meaningful change of a numerical rating scale for worst pain associated with dysmenorrhea (NRS-DYS) and nonmenstrual pelvic pain (NRS-NMPP) in women with mode…

2020
·doi:10.1016/j.fertnstert.2020.08.206
2020
·doi:10.1016/j.fertnstert.2020.08.576
rct 2020
Fertility and sterility ·doi:10.1016/j.fertnstert.2020.02.114

OBJECTIVE: To study the effect of a new investigational oral gonadotropin-releasing hormone antagonist, linzagolix, on endometriosis-associated pain (EAP). DESIGN: A multinational, parallel group, randomized, placebo-controlled, double-bli…

rct 2019
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2019.11.1255

BACKGROUND: Endometriosis-related pain symptoms have a negative impact on health-related quality of life and productivity. In fact, as endometriosis-related symptom severity and the number of symptoms experienced increases, health-related q…

lab-animal 2019
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-019-0480-0

BACKGROUND: Endometriosis is an estrogen dependent, inflammatory disorder occurring in 5-10% of reproductive-aged women. Women with endometriosis have a lower body mass index (BMI) and decreased body fat compared to those without the diseas…

lab-animal 2019
PLoS biology ·doi:10.1371/journal.pbio.3000421

Decidua is a transient uterine tissue shared by mammals with hemochorial placenta and is essential for pregnancy. The decidua is infiltrated by many immune cells promoting pregnancy. Adult bone marrow (BM)-derived cells (BMDCs) differentiat…

2019
·doi:10.1177/2284026519864232

Background: The daily pain burden experienced by women with endometriosis has not been well studied. Objective: To characterize baseline pain among women with moderate-to-severe endometriosis-associated pain enrolled in phase 3 studies of e…

lab-animal 2019
Biology of reproduction ·doi:10.1093/biolre/ioy265

Angiogenesis is essential for cyclic endometrial growth, implantation, and pregnancy maintenance. Vasculogenesis, the formation of new blood vessels by bone marrow (BM)-derived endothelial progenitor cells (EPCs), has been shown to contribu…

review 2019
Obstetrical & gynecological survey ·doi:10.1097/ogx.0000000000000718

IMPORTANCE: While it has long been known that polycystic ovarian syndrome is associated with cardiometabolic risk factors (CMRFs), there is emerging evidence that other benign gynecologic conditions, such as uterine leiomyomas, endometriosi…

other 2019
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2018.12.039

Endometriosis can have a profound impact on women's lives, including associated pain, infertility, decreased quality of life, and interference with daily life, relationships, and livelihood. The first step in alleviating these adverse seque…